BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹52 Cr | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹52 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹22 Cr |
| Mar2021 | ₹24 Cr |
How is Total Current Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹52 Cr | -4.13 | |
| Mar2024 | ₹54 Cr | 16.37 | |
| Mar2023 | ₹46 Cr | 111.13 | |
| Mar2022 | ₹22 Cr | -9.45 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹585.6 Cr | -7.7% | 6.1% | 179.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -7.7% |
6.1% |
179.9% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses